Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 696-700

  Geng, Chang Xin ^a   Zeng, Zhao Chong ^a   Wang, Ji Yao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL CYCLE G2 PHASE; CLONOGENIC ASSAY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CELL; LIVER CELL CARCINOMA; STATISTICAL ANALYSIS;

EID: 0037963076     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.696     Document Type: Article

References (36)

1. Gueritte-Voegelein F, Guenard D, Lavelle F, Le Goff MT, Mangatal L, Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 1991; 34: 992-998
2. Donnellan P, Armstrong J, Rowan S, Fennelly D, Lynch V, McDonnell T, McDonnell T, McNicholas W, Crown J. New chemotherapy combination with docetaxel in the treatment of patients with non-small cell lung cancer. Semin Oncol 1998; 25: 20-23
3. Coleman RE, Howell A, Eggleton SP, Maling SJ, Miles DW. Phase II study of docetaxel in patients with liver metastases from breast cancer. Ann Oncol 2000; 11: 541-546
4. Papakostas P, Kourousis C, Androulakis N, Samelisi G, Aravantinos G, Kalbakis K, Sarra E, Souglakos J, Kakolyris S, Georgoulias V. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 2001; 37: 1833-1838
5. Glisson BS, Murphy BA, Frenette G, Khuri FR, Forastiere AA. Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. J Clin Oncol 2002; 20: 1593-1599
6. Wenzel C, Locker GJ, Schmidinger M, Rudas M, Taucher S, Gnant MF, Jakesz R, Steger GG. Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel plus granulocyte colony stimulating factor. Anticancer Drugs 2002; 13: 67-74
7. Cascinu S, Graziano F, Barni S, Labianca R, Comella G, Casaretti R, Frontini L, Catalano V, Baldelli AM, Catalano G. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. Br J Cancer 2001; 84: 470-474
8. Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. A phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer 2002; 94: 97-103
9. Sinibaldii VJ, Carducci MA, Moore-Cooper S, Laufer M, Zahurak M, Eisenberger MA. Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma. Cancer 2002; 94: 1457-1465
10. Wu MC. Clinical research advances in primary liver cancer. World J Gastroenterol 1998; 4: 471-474
11. Yip D, Findlay M, Boyer M, Tattersall MH. Hepatocellular carcinoma in central Sydney: A 10-year review of patients seen in a medical oncology department. World J Gastroenterol 1999; 59: 483-487.
12. Schmid R. Prospect of gastroenterology and hepatology in the next century. World J Gastroenterol 1999; 5: 185-190
13. Qin LX, Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 193-199
14. Vanhoefer U, Cao S, Harstrick A, Seeber S, Rustum YM. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpresses the multidrug resistance protein (MRP). Ann Oncol 1997; 8: 1221-1228
15. Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, Andre S. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 1995; 22: 3-16
16. McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, Nishioka WK, Green DR. The end of the (cell) line: Methods for the study of apoptosis in vitro. Methods Cell Biol 1995; 46: 153-185
17. Lin HL, Liu TY, Chau GY, Luii WY, Chi CW. Comparison of 2-methoxyestrodiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 2000; 89: 983-994
18. Shen HM, Yang CF, Ong CN. Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells. Int J Cancer 1999; 81: 820-828
19. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995; 358: 1-3
20. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998; 280: 898-902
21. Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280: 599-602
22. Martinez JD, Pennington ME, Craven MT, Warters RL, Cress AE. Free radicals generated by ionizing radiation signal nuclear translocation of p53. Cell Growth Diff 1997; 8: 941-949
23. Ueda S, Nakamura H, Masutani H, Sasada T, Takabayashi A, Yamaoka Y, Yodoi J. Baicalin induces apoptosis via mitochondrial pathway as prooxidant. Mol Immunol 2002; 38: 781-791
24. Li HL, Chen DD, Li XH, Zhang HW, Lu YQ, Ye CL, Ren XD. Changes of NF-κB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: Role of reactive oxygen species. World J Gastroenterol 2002; 8: 431-435
25. Simizu S, Takada M, Umezawa K, Imoto M. Requirement of caspase-3 (like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998; 273: 26900-26907
26. Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2002; 291: 861-867
27. Koren R, Rocker D, Kotestiano O, Liberman UA, Ravid A. Synergistic anticancer activity of 1, 25-dihydroxy vitamin D(3) and immune cytokines: The involvement of reactive oxygen species. J Steroid Biochem Mol Biol 2000; 73: 105-112
28. Teramoto S, Tomita T, Matsui H, Ohga E, Matsuse T, Ouchi Y. Hydrogen peroxide-induced apoptosis and necrosis in human lung fibroblasts: Protective roles of glutathione. Jpn J Pharmacol 1999; 79: 33-40
29. Liu J, Shen HM, Ong CN. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells. Cancer Letters 2000; 153: 85-93
30. Hall AG. The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 1999; 29: 238-245
31. Wedi B, Straede J, Wieland B, Kapp A. Eosinophil apoptosis is mediated by stimulators of cellular oxidative metabolisms and inhibited by antioxidants: Involvement of a thiol-sensitive redox regulation in eosinophil cell death. Blood 1999; 94: 2365-2373
32. Watson RW, Rotstein OD, Nathens AB, Dackiw AP, Marshall JC. Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 1996; 120: 150-157
33. Van Den Dobbelsteen DJ, Nobel CS, Schlegel J, Cotgreave IA, Orrenius S, Slater AF. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J Biol Chem 1996; 271: 15420-15427
34. Lavrentiadou SN, Chan C, Kawcak T, Ravid T, Tsaba A, Van Der Vliet A, Rasooly R, Goldkorn T. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione. Am J Respir Cell Mol Biol 2001; 25: 676-684
35. Chang WK, Yang KD, Shaio MF. Lymphocyte proliferation modulated by glutamine: Involved in the endogenous redox reaction. Clin Exp Immunol 1999; 117: 482-488
36. Noda T, Iwakiri R, Fujimoto K, Aw TY. Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells. FASEB J 2001; 15: 2131-2139